5-HT1A-Receptor Subtype Mediates the Effect of Fluvoxamine, a Selective Serotonin Reuptake Inhibitor, on Marble-Burying Behavior in Mice

The Japanese Journal of Pharmacology

Volumn 68, Issue 1, 1995, Pages 65-70

  Ichimaru, Yasuyuki ^a   Egawa, Takashi ^a   Sawa, Aiko ^a  

^a MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

Fluvoxamine; Marble burying; Obsessive compulsive disorder; Selective serotonin reuptake inhibitor

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; BENZODIAZEPINE; BUSPIRONE; CLOMIPRAMINE; DESIPRAMINE; DIAZEPAM; FLUVOXAMINE; RECEPTOR SUBTYPE; RITANSERIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ANTI ANXIETY AGENTS; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; SEROTONIN RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; OBSESSION; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; DOSE RESPONSE; METABOLISM; MOUSE STRAIN; TIME;

ANALYSIS OF VARIANCE; ANIMAL; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUVOXAMINE; MALE; MICE; MICE, INBRED ICR; RECEPTORS, SEROTONIN; TIME FACTORS;

EID: 0028989562     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.68.65     Document Type: Article

References (17)

1. Montgomery SA: Clinical efficacy of 5-HT uptake inhibitors. Neuropharmacology 13, 285–286 (1990)
2. Kahn RJ, Westenberg HG and Jolies J: Zimelidine treatment of obsessive-compulsive disorder; biological neuropsychological aspects. Acta Psychiatry Scand 69, 259–261 (1984)
3. Delgado LP, Goodman KW, Price HL, Heninger RG and Charney SD: Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder. Br J Psychiatry 157, 762–765 (1990)
4. Lopez-Ibor JJ Jr: Serotonin and psychiatric disorders. Intern Clin Psychopharmacol 7, Supp 2, 5–11 (1992)
5. Ichimaru Y, Egawa T, Hiranuma T and Sawa A: Effect of fluvoxamine on tail-suspension-induced immobility in mice. Pharmacometrics 49, 375–378 (1995) (Abstr in English)
6. 2-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on forced-swimming-induced immobility in mice. Jpn J Pharmacol 68, 71–75 (1995)
7. Broekkamp CL and Jenck F: The relationship between various animal models of anxiety, fear-related psychiatric symptoms and response to serotonergic drugs. In Behavioral Pharmacology of 5-HT, Edited by Bevan P, Cools R and Archer T, pp 321–335, Erlbaum, Hillsdale (1989)
8. Njung'e K and Handley SL: Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 38, 63–67 (1991)
9. Njung'e K and Handley SL: Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Br J Pharmacol 104, 105–112 (1991)
10. Broekkamp CL, Rijk HW, Gelouin JD and Lloyd KL: Major tranquilizers can be distinguished from minor tranquilizers on the basis of effects on marble-burying behavior and swim-induced grooming in mice. Eur J Pharmacol 126, 223–229 (1986)
11. Ichimaru Y, Egawa T, Imanishi T and Sawa A: Behavioral effects of fluvoxamine on several paradigms in rodents. Abstr Soc Neurosci 18, 727 (1992)
12. Greist JH: An integrated approach to treatment of obsessive compulsive disorder. J Clin Psychiatry 53, Supp 4, 38–41 (1992)
13. Eison AS, Eison MS, Stanley M and Riblet L: Serotonergic mechanisms in the behavioral effects of buspirone and gepirone. Pharmacol Biochem Behav 24, 701–707 (1986)
14. Dresse A and ScuveeMoreau J: The effects of various antidepressants on the spontaneous firing rates of noradrenergic and serotonergic neurons. Clin Neuropharmacol 7, Supp 572–573 (1984)
15. Fernandez-Guasti A, Lopez-Rubalcave C, Perez-Urizar J and Castaneda-Hernandez G: Evidence for a postsynaptic action of the serotonergic anxiolytics: ipsapirone, indorenate and buspirone. Brain Res Bull 28, 497–501 (1992)
16. Bel N and Artigas F: Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 229, 101–103 (1992)
17. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1, 470–480 (1987)